3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
10
Thoracic
2
Other hematologic neoplasm
2
Gynecologic
2
Genitourinary
2
Endocrine
2
Plasma cell
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Classical hematology
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
354
Hematologic Neoplasms
272
Leukemia, Myeloid, Acute
255
Leukemia
234
Lymphoma
127
Leukemia, Lymphocytic, Chronic, B-Cell
110
Multiple Myeloma
108
Neoplasms
95
Myelodysplastic Syndromes
95
Lymphoma, Non-Hodgkin
94
Hodgkin Disease
76
Burkitt Lymphoma
64
Lymphoma, Mantle-Cell
61
Lymphoma, Follicular
60
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
60
Lymphoma, Large B-Cell, Diffuse
56
Myeloproliferative Disorders
54
Lymphoma, B-Cell, Marginal Zone
53
Lymphoma, Large-Cell, Immunoblastic
47
Congenital Abnormalities
47
Motor Activity
45
Leukemia, Myeloid, Chronic-Phase
45
Primary Myelofibrosis
43
Lymphoma, T-Cell, Cutaneous
43
Recurrence
41
Sezary Syndrome
39
Mycosis Fungoides
39
Leukemia, Myeloid, Accelerated Phase
38
Neoplasms, Plasma Cell
35
Breast Neoplasms
35
Interventions
Therapeutics
1
Geriatric Assessment
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase NA
×
Treatment Adherence and Compliance
×
Other hematologic neoplasm
×
Clear all
NCT05260203
2024-11-06
MargheRITA
Advice Pharma Group srl
Phase NA
Completed
124 enrolled
NCT06373471
2024-04-18
IMPROVE
Odense University Hospital
Phase NA
Recruiting
152 enrolled